Holen Sie sich die Stockscreener-App
2.61
3.33%
-0.09
Handel nachbörslich:
2.50
-0.11
-4.21%
Schlusskurs vom Vortag:
$2.70
Offen:
$2.57
24-Stunden-Volumen:
1.42M
Relative Volume:
1.09
Marktkapitalisierung:
$24.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-45.57M
KGV:
-0.4143
EPS:
-6.3
Netto-Cashflow:
$-38.56M
1W Leistung:
+2.76%
1M Leistung:
+45.81%
6M Leistung:
-29.84%
1J Leistung:
-8.26%
1-Tages-Spanne:
$2.245
$2.69
1-Wochen-Bereich:
$2.245
$6.60
52-Wochen-Spanne:
$1.00
$6.60
Sab Biotherapeutics Inc Stock (SABS) Company Profile
Firmenname
Sab Biotherapeutics Inc
Sektor
Branche
Telefon
305-845-2813
Adresse
777 W 41ST ST, MIAMI BEACH
Vergleichen Sie SABS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SABS
Sab Biotherapeutics Inc
|
2.61 | 23.59M | 0 | -45.57M | -38.56M | -6.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-10-09 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-28 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-05 | Eingeleitet | Chardan Capital Markets | Buy |
Sab Biotherapeutics Inc Aktie (SABS) Neueste Nachrichten
SAB Biotherapeutics Inc. Stock Analysis and ForecastTremendous return rates - jammulinksnews.com
What drives SAB Biotherapeutics Inc. Equity Warrant stock priceBreakthrough profit margins - jammulinksnews.com
What analysts say about SAB Biotherapeutics Inc. stockSuperior risk-adjusted returns - jammulinksnews.com
What analysts say about SAB Biotherapeutics Inc. Equity Warrant stockExceptional financial outcomes - jammulinksnews.com
Is SAB Biotherapeutics Inc. Equity Warrant a good long term investmentExplosive portfolio gains - jammulinksnews.com
What drives SAB Biotherapeutics Inc. stock priceFree Stock Market Mentorship - jammulinksnews.com
SAB Biotherapeutics stock price target lowered to $9 by H.C. Wainwright - Investing.com Canada
SAB Biotherapeutics Shares Jump 33% After Securing $175M in Oversubscribed Private Placement - MSN
SAB Biotherapeutics Inc. Equity Warrant Stock Analysis and ForecastExtraordinary market timing - jammulinksnews.com
SAB Biotherapeutics stock price target raised to $14 from $12 at Oppenheimer - Investing.com Canada
SAB Biotherapeutics Inc (SABS) Stock: A Year of Market Movement, Down and Up - investchronicle.com
SABS Soars 24.5% on Volatile Intraday Surge—What’s Fueling the Biotech Rally? - AInvest
SAB Biotherapeutics (SABS) up more than 100% since Jun 30 - AInvest
SAB Biotherapeutics Stock Surge: Should You Buy? - StocksToTrade
SAB Biotherapeutics stock soars after securing $175 million private placement By Investing.com - Investing.com Nigeria
SAB Biotherapeutics stock soars after securing $175 million private placement - Investing.com India
SAB BIO Stock Explodes 54% on Game-Changing $175 Million Private Placement Deal - RagingBull
SAB Biotherapeutics Secures $175M in Private Placement - TipRanks
SAB Biotherapeutics announces oversubscribed $175M private placement - TipRanks
SAB BIO Announces Oversubscribed $175 Million Private Placement - GlobeNewswire
SAB BIO Secures $175M Funding Led by Sanofi to Advance Revolutionary Type 1 Diabetes Treatment Through 2028 - Stock Titan
SABS Stock on the Rise: What’s Next? - timothysykes.com
Published on: 2025-07-20 20:52:24 - jammulinksnews.com
Is SAB Biotherapeutics Inc. a good long term investmentTriple-digit return opportunities - Autocar Professional
What analysts say about NVTS stockGame-changing capital returns - Jammu Links News
What analysts say about Equifax Inc. stockFree Investment Case Studies - Jammu Links News
FIZZ Stock Analysis and ForecastRapid market gains - Jammu Links News
Best Healthcare Stocks Well Researched Investment IdeasSuperior capital gains - Jammu Links News
SAB Biotherapeutics Holds Annual Stockholders Meeting - TipRanks
Why SAB Biotherapeutics Inc. Equity Warrant stock attracts strong analyst attentionFree Daily Stock Market Updates - beatles.ru
Why SAB Biotherapeutics Inc. stock attracts strong analyst attentionFree Access to Investment Community - Newser
Why DUOL stock attracts strong analyst attentionHigh Return Setup Scanner - Newser
What makes SAB Biotherapeutics Inc. stock price move sharplyBreakout Confirmation Tool - Newser
How SAB Biotherapeutics Inc. stock performs during market volatilityLow Risk Trading Ideas - Newser
Finanzdaten der Sab Biotherapeutics Inc-Aktie (SABS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):